(Q37782029)

23 August 2017

title

State-of-the-art issues in Hodgkin's lymphoma survivorship (English)

1 reference

23 August 2017

State-of-the-art Issues in Hodgkin’s Lymphoma Survivorship (English)

1 reference

https://api.crossref.org/works/10.1007/S11912-010-0123-2

21 June 2024

2

Matthew J. Matasar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20734173

21 June 2024

author name string

Shrujal S. Baxi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20734173

21 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20734173

21 June 2024

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

http://www.current-reports.com/1523-3790/12/366

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20734173

http://link.springer.com/content/pdf/10.1007/s11912-010-0123-2.pdf

21 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11912-010-0123-2

http://link.springer.com/article/10.1007/s11912-010-0123-2/fulltext.html

21 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11912-010-0123-2

http://link.springer.com/content/pdf/10.1007/s11912-010-0123-2

21 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11912-010-0123-2

21 June 2024

published in

Current Oncology Reports

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

366-373

1 reference

The involved field is back: issues in delineating the radiation field in Hodgkin's disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Late effects of treatment for early-stage Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Leukemia following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Preservation of fertility in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Preserving female fertility following cancer treatment: current options and future possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Fatigue in long-term Hodgkin's Disease survivors: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-010-0123-2

Late medical complications and fatigue in Hodgkin's disease survivors.

21 January 2018

1 reference

12 December 2020

Second cancer risk following Hodgkin's disease: a 20-year follow-up study

1 reference

12 December 2020

Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma

1 reference

12 December 2020

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease

1 reference

12 December 2020

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation

1 reference

12 December 2020

Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms

1 reference

12 December 2020

Thyroid toxicity of treatment for Hodgkin's disease

1 reference

12 December 2020

Psychosocial problems among survivors of Hodgkin's disease

1 reference

12 December 2020

Cardiac lesions after mediastinal irradiation for Hodgkin's disease

1 reference

12 December 2020

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

1 reference

12 December 2020

Late cardiotoxicity after treatment for Hodgkin lymphoma

1 reference

12 December 2020

Major complications and causes of death in patients treated for Hodgkin's disease

1 reference

12 December 2020

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

1 reference

12 December 2020

Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B

1 reference

12 December 2020

Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD

1 reference

12 December 2020

Nemaline myopathy: a possible late complication of Hodgkin’s disease therapy

1 reference

12 December 2020

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

1 reference

12 December 2020

Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma

1 reference

12 December 2020

Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer

1 reference

12 December 2020

Long-term cancer survivors experience work changes after diagnosis: results of a population-based study

1 reference

12 December 2020

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

1 reference

12 December 2020

Long-term cause-specific mortality of patients treated for Hodgkin's disease

1 reference

12 December 2020

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

1 reference

12 December 2020

Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome

1 reference

12 December 2020

Identifiers

1 reference

23 August 2017

1 reference